Panel Discussion: Advancing Scalable Gene Editing Manufacturing & CDMO Collaboration to Preserve Product Quality & Reduce Timelines

• Streamlining manufacturing and analytical collaboration to preserve product purity, potency, and consistency throughout scale-up
• Optimizing CDMO partnerships and tech transfer strategies to reduce development delays and manufacturing inefficiencies
• Exploring flexible guide RNA manufacturing approaches to support scalable production across diverse rare disease populations

Speakers:

Cindy Liu

Director, Molecular Analytical Development

Prime Medicine

Wei-chiang chen

Associate Director

Sanofi

Gopi Shanker

Chief Scientific Officer

Beam Therapeutics